LON:VAL ValiRx Interim Earnings Report GBX 0.17 0.00 (-1.71%) As of 11:57 AM Eastern ProfileEarnings History ValiRx EPS ResultsActual EPS-GBX 0.22Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/AValiRx Revenue ResultsActual RevenueN/AExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AValiRx Announcement DetailsQuarterInterimDate9/29/2025TimeBefore Market OpensConference Call DateN/AConference Call TimeN/AConference Call ResourcesEarnings HistoryCompany Profile ValiRx Earnings HeadlinesValiRx Streamlines Operations and Sharpens Strategy as Auditors Highlight Funding Uncertainty (VAL)June 23 at 9:03 AM | uk.finance.yahoo.comTRADING UPDATES: Maintel fundraising completes; ValiRx ends dealJune 22 at 10:09 AM | lse.co.ukBLOODBATH: 80% Dow Drop Predicted – Former Pentagon AdvisorA former advisor to the Pentagon and CIA is warning that an 80% Dow drop could arrive within days - and names Sam Altman, Michael Burry, and Stanley Druckenmiller among those already preparing. His AI Black Paper details the timing, the reasoning, and 3 critical steps investors can take now - including one strategy positioned to deliver returns as high as 600% as the downturn unfolds.June 24 at 1:00 AM | Paradigm Press (Ad)ValiRx tightens focus and cuts costs as auditors flag going-concern riskJune 22 at 2:30 AM | tipranks.comValiRx Ends Dundee Evaluation After Cancer Asset Fails Licensing CriteriaJune 22 at 2:10 AM | tipranks.comValiRx (LON:VAL) Share Price Passes Below 200-Day Moving Average - Here's What HappenedJune 17, 2026 | americanbankingnews.comSee More ValiRx Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like ValiRx? Sign up for Earnings360's daily newsletter to receive timely earnings updates on ValiRx and other key companies, straight to your email. Email Address About ValiRxValiRx (LON:VAL) accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.View ValiRx ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Why nVent Could Be a Long-Term AI Infrastructure WinnerChevron’s Microsoft Deal Turns Natural Gas Into an AI TradeMicron’s Sudden Plunge May Be an AI Buying ChanceMarathon Petroleum Is Back, But Cycles Still MatterLiquid Gold: The AI Cooling Retrofit TradeCopa Holdings May Be the Airline Stock Built to Break OutBuy CrowdStrike Before the Stock Split? Here's the Case Upcoming Earnings NIKE (6/30/2026)PepsiCo (7/9/2026)Delta Air Lines (7/9/2026)Fastenal (7/13/2026)Bank of America (7/14/2026)The Goldman Sachs Group (7/14/2026)JPMorgan Chase & Co. (7/14/2026)Wells Fargo & Company (7/14/2026)Citigroup (7/14/2026)ASML (7/15/2026) Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
